These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases]. Larrain C; Cruz A; Codoceo V Rev Med Chil; 1984 Sep; 112(9):898-911. PubMed ID: 6598227 [No Abstract] [Full Text] [Related]
3. [Survival of 29 cases of chronic myeloid leukemia treated by myleran]. Petitclerc C; Barry A Union Med Can; 1976 Feb; 105(2):210-6. PubMed ID: 1069396 [No Abstract] [Full Text] [Related]
4. Delayed toxic effect of busulfan on the marrow. Ganda OP; Mangalik A J Assoc Physicians India; 1973 Jun; 21(6):511-6. PubMed ID: 4525264 [No Abstract] [Full Text] [Related]
6. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan. Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954 [No Abstract] [Full Text] [Related]
7. [Effect of busulfan-treated granulocytic leukemia on pregnancy, labor and the somatic condition of the newborn infant]. Szmigiel Z; Kowalska J; Szczepaniak AM Przegl Lek; 1986; 43(9):632-4. PubMed ID: 3468559 [No Abstract] [Full Text] [Related]
15. [Reversible pituitary-adrenal insufficiency produced by busulfan]. García-San Miguel J; Pujol-Moix N Rev Clin Esp; 1968 Sep; 110(5):467-72. PubMed ID: 4247382 [No Abstract] [Full Text] [Related]
16. [Fatal pulmonary fibrosis, with cellular lesions of the lung and pancreas, attributed to busulfan]. Batzenschlager A; Oberling F; Guerbaoui M; Vetter JM Arch Anat Pathol (Paris); 1972 Sep; 20(3):291-4. PubMed ID: 4507846 [No Abstract] [Full Text] [Related]
17. Histopathology and ultrastructure of busulfan-induced cataract. Hamming NA; Apple DJ; Goldberg MF Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1976 Aug; 200(2):139-47. PubMed ID: 1086604 [TBL] [Abstract][Full Text] [Related]
18. [Serious hematological accidents due to Myleran in the treatment of chronic myeloid leukemia]. Olmer J; Muratore R; Gabriel B; Canu AM Mars Med; 1968; 105(4):330-8. PubMed ID: 5245481 [No Abstract] [Full Text] [Related]
19. [Degenerative retinal conditions after treatment with Busulfan during pregnancy (author's transl)]. Saraux H; Lefrancois A Klin Monbl Augenheilkd; 1977 Jun; 170(6):818-20. PubMed ID: 268448 [TBL] [Abstract][Full Text] [Related]
20. [Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia]. Japp H Schweiz Med Wochenschr; 1974 Aug; 104(32):1115-9. PubMed ID: 4548568 [No Abstract] [Full Text] [Related] [Next] [New Search]